about
Potential therapeutic targets for neurokinin-1 receptor antagonistsSubstance P and Substance P receptor antagonists in the pathogenesis and treatment of affective disorders.The mammalian tachykinin ligand-receptor system: an emerging target for central neurological disordersCurrent progress in the pharmacological therapy of fibromyalgia.Neuropeptides CRH, SP, HK-1, and Inflammatory Cytokines IL-6 and TNF Are Increased in Serum of Patients with Fibromyalgia Syndrome, Implicating Mast Cells.Fibromyalgia and sleep in animal models: a current overview and future directions.
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
The promise of substance P inhibitors in fibromyalgia.
@ast
The promise of substance P inhibitors in fibromyalgia.
@en
The promise of substance P inhibitors in fibromyalgia.
@nl
type
label
The promise of substance P inhibitors in fibromyalgia.
@ast
The promise of substance P inhibitors in fibromyalgia.
@en
The promise of substance P inhibitors in fibromyalgia.
@nl
prefLabel
The promise of substance P inhibitors in fibromyalgia.
@ast
The promise of substance P inhibitors in fibromyalgia.
@en
The promise of substance P inhibitors in fibromyalgia.
@nl
P921
P1476
The promise of substance P inhibitors in fibromyalgia.
@en
P2093
I Jon Russell
P304
P356
10.1016/S0889-857X(01)00006-0
P577
2002-05-01T00:00:00Z